- $13.11bn
- $14.19bn
- $14.38bn
- 96
- 42
- 70
- 79
R2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13,642 | 13,240 | 13,341 | 13,148 | 14,378 |
Cost of Revenue | |||||
Gross Profit | 612 | 710 | 798 | 848 | 945 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13,246 | 12,859 | 12,711 | 12,501 | 14,054 |
Operating Profit | 396 | 381 | 630 | 647 | 324 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 249 | 233 | 409 | 551 | 213 |
Provision for Income Taxes | |||||
Net Income After Taxes | 234 | 187 | 320 | 415 | 157 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -261 | -186 | 173 | 311 | 55.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -261 | -186 | 173 | 311 | 55.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.03 | 2.02 | 2.22 | 3.29 | 1.81 |
Dividends per Share |